Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELUW) Change in Cash (2020 - 2025)

Historic Change in Cash for Celularity (CELUW) over the last 6 years, with Q3 2025 value amounting to -$681000.0.

  • Celularity's Change in Cash fell 20538.12% to -$681000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$76000.0, marking a year-over-year increase of 9840.57%. This contributed to the annual value of $814000.0 for FY2024, which is 10436.72% up from last year.
  • Celularity's Change in Cash amounted to -$681000.0 in Q3 2025, which was down 20538.12% from $632000.0 recorded in Q2 2025.
  • Celularity's 5-year Change in Cash high stood at $64.5 million for Q3 2021, and its period low was -$35.4 million during Q4 2021.
  • In the last 5 years, Celularity's Change in Cash had a median value of -$1.4 million in 2024 and averaged -$3.1 million.
  • In the last 5 years, Celularity's Change in Cash plummeted by 752017.78% in 2021 and then surged by 14533.72% in 2025.
  • Over the past 5 years, Celularity's Change in Cash (Quarter) stood at -$35.4 million in 2021, then grew by 18.9% to -$28.7 million in 2022, then surged by 82.79% to -$4.9 million in 2023, then soared by 113.09% to $646000.0 in 2024, then tumbled by 205.42% to -$681000.0 in 2025.
  • Its Change in Cash stands at -$681000.0 for Q3 2025, versus $632000.0 for Q2 2025 and -$673000.0 for Q1 2025.